Professional Documents
Culture Documents
Severe Pre Eclampsia Final Draft
Severe Pre Eclampsia Final Draft
The researchers would like to reach out our most profound appreciation and
appreciation to those individuals who had made a difference in the completion of this
study. The researchers would like to express their sincerest gratitude and appreciation
towards these individuals who were with them from the start of our journey and to those
individuals who lend their assistance to make this study possible. First and foremost,
praises and thanks to God, the Almighty, for His showers of blessings throughout the
case study and its successful completion. The researchers would also like to express
their deep and sincere gratitude to the RLE advisers, for providing them the invaluable
supervision, support, and tutelage during the course of the study. Gratitude will also be
given to them for their empathy, patience, and knowledge that they imparted. It was a
great privilege and honor to work and study under their guidance. Thanks, and
appreciations also go to the patient who willingly helped with his full cooperation which
has made the research study achieve its smooth completion. Also like to give thanks for
the time and knowledge that you have given to conduct this study. Last but not the
least, to our dearest parents for their deep consideration for the finances and undying
support throughout the making of the case study. As well as for their words of
encouragement to all those nights that we have spent making this case study.
The Researchers,
1
I. Introduction
Pre- eclampsia can be particularly dangerous because many of the signs are
silent while some symptoms resemble " normal" effects of pregnancy on our body.
Many women sufferings from pre- eclampsia don't feel sick and maybe surprised or
become frustrated when they are admitted in hospital. High blood pressure is an
important sign of pre- eclampsia. The disease is sometimes referred to as a silent killer
because most people can't feel their blood pressure going up. As a result, patient
awareness of the warning signs is one of most important tools we must successfully
help women receive the care they need.
In the Philippines, a total of 202 women were included in the analysis where 24
(11.9%), 11(5.4%) and 13 (6.4%) developed pre- eclampsia, early onset pre- eclampsia
and late onset pre- eclampsia.
2
II. Objectives
General Objectives
Specific Objectives
3
III. Patient’s Data
Biographical Data
Name: Mrs. A
Sex: Female
Religion: Islam
Nationality: Filipino
Admission History
I. Chief Complaint: Severe abdominal pain
4
IV. Personal/Social/Health History
Ms. A was a G2 P1 pregnancy uterine 38 weeks AOG by last menstrual period.
Cephalic in labor. She was previously undergone cesarean section on her first baby
way back 2021 due to Eclampsia. She had no history of any major illnesses. She
also completed her COVID vaccines which is the Pfizer, she is also a complete
immunize child. Before she went to the hospital, Mrs. A did not take any drugs or
vitamins. Her menarche was on April of 2011 when she was 12 years old. She has a
regular menstruation and she is not using any contraceptives.
5
V. Family Background and Health History
GENOGRAM
MOTHER FATHER
PATIENT
SIBLING 1
CHILD 1 FETUS
LEGEND:
6
The patient is a 25 years old female. Lives in Lower Paatan, Kabacan, North
Cotabato. The health background of the patient, on the paternal side, all members of
the family have no major diagnosis. The maternal side, all members of the family have
no major diagnosis, except for the mother of the patient who is diagnosed with diabetes
mellitus. Finally, Mrs. A is pregnant and has a fetus inside her womb at 38 weeks age of
gestation.
7
VI. Developmental Data
Theory)
8
(Hierarchy of Needs)
problems.
(Cognitive Development)
9
VII. Definition of Complete Diagnosis
weeks of pregnancy and at least one of the following findings: Protein in your urine
(proteinuria), indicating an impaired kidney. Other signs of kidney problems. A low blood
platelet count.
Severe preeclampsia occurs when a pregnant woman has any of the following:
Systolic blood pressure of 160 mmHg or higher or diastolic blood pressure of 110
mmHg or higher on two occasions at least 4 hours apart while the patient is on bed rest.
10
VIII. Physical Assessment
System Findings
General Appearance Patient is conscious and anxious.
Patient is oriented to time, place and people.
Patient able to answer questions directly.
Patient appears in significant discomfort.
Height: 152 cm
Weight: 78 kg
BMI: 33.76 - Obese
Vital Signs Blood Pressure: 160/100 mmHg
Pulse Rate: 89 bpm
Respiratory Rate: 21 cpm
Temperature: 36.5 oC
Oxygen Saturation: 98%
Skin, Hair and Nails Skin is smooth and moistened, skin color is light
brown.
Hair color is black.
Nails are neatly trimmed and clean
Capillary refill test resulted with <3 seconds normal
return of color.
HEENT Patient complain headache and reported slight
(Head, Ears, Eyes, Nose disturbance in vision.
and Throat) Skull is symmetrical, round and erect on midline with
no tenderness and any deformities.
Swelled face.
Peri-orbital edema present around the eyes.
Good eye movement and coordination.
Pupils are equal and round, reactive to light and
accommodation.
11
Ears are bilaterally symmetrical and sound heard
equally on both ears.
No discharges, redness, or masses, small amount of
cerumen is present.
Nose is located midline, symmetrical with no
discharge.
Lip is light pink in color, moist, no discoloration or
cracks.
Pink gums with no inflammation, swelling or
redness.
Throat has no inflammation or swelling, and no
difficulty of swelling.
Thorax and Lungs Bilateral chest appears symmetrical with sternum
located at midline.
Equal expansion of both lungs.
Breathing sounds are clear.
Breast Bilateral breast appears symmetrical without visible
deformities.
Nipples are appointed in same direction.
No swelling or discharge seen.
Abdomen Round shape, no distention or lesions, previous
incisional scar is present.
Linea nigra and striae gravidarum present.
Fundal height at 38 cm.
Genital Area No discoloration, swelling, or redness,
No abnormal vaginal discharge or any abnormalities.
Lower Extremities Bilaterally symmetrical, no visible deformity.
Skin is warm to touch.
Edema is present on both feet.
No extra digits.
12
Fetal Assessment
Systems Findings
Fetal Heart Rate 154 bpm
Fetal Presentation Cephalic presentation
Fetal Movement Active fetal movement and cardiac
activity
Fetal Weight Estimated fetal weight of 1409 grams
Fetal Length Approximately 46 cm
13
VIII. Anatomy and Physiology
dysfunction.
14
pulmonary edema, a condition where fluid accumulates in the lungs. This fluid buildup
makes it difficult for oxygen to
respiratory distress.
15
visual disturbances such as blurred vision, sensitivity to light, or temporary vision loss.
This is known as hypertensive retinopathy.
16
IX. Etiology and Symptomatology
ETIOLOGY
17
them not work as they should. mitigate the severity of
As a result, this can lead to a preeclampsia.
condition called preeclampsia,
which can cause high blood
pressure and other
complications during
pregnancy.
Placental Reduced placental perfusion Induces maternal endothelial
Ischemia/ due to impaired spiral artery dysfunction, hypertension, and
Hypoxia remodeling leads to placental proteinuria, highlighting
ischemia and hypoxia, potential therapeutic avenues.
triggering the release of
factors like soluble fms-like
tyrosine kinase-1 (sFlt-1) and
soluble endoglin (sEng).
Diabetes Diabetes induces systemic Poorly controlled diabetes
Mellitus endothelial dysfunction, escalates pre-eclampsia
heightening susceptibility to severity, necessitating vigilant
pre-eclampsia's vascular monitoring and early
complications. intervention to reduce maternal
and fetal risks.
Hypertension High blood pressure triggers Hypertension, especially when
vascular remodeling, combined with other risk
inflammation, and oxidative factors like diabetes, amplifies
stress, predisposing to pre- the likelihood of severe pre-
eclampsia development. eclampsia, leading to serious
maternal and fetal
complications. Effective
hypertension management in
pregnancy is vital to mitigate
pre-eclampsia risks.
18
Kidney Pre-existing kidney disease is Managing and optimizing renal
Diesease a significant risk factor for function before and during
developing preeclampsia due pregnancy in women with
to altered renal function, kidney disease are essential
increased systemic for reducing the risk and
inflammation, and endothelial severity of preeclampsia.
dysfunction. Kidney disease Close collaboration between
can also lead to hypertension nephrologists and obstetricians
and proteinuria, which are is crucial in providing
cardinal features of comprehensive care to these
preeclampsia. high-risk individuals.
Advanced Advanced maternal age (e.g. As more women delay
Maternal Age over 35 years old) is childbearing, understanding
associated with changes in the unique challenges and
vascular function, oxidative risks associated with advanced
stress, and decreased maternal age becomes critical.
uteroplacental perfusion, all of Prenatal care strategies
which are factors that can tailored to older mothers,
contribute to preeclampsia. including close monitoring of
blood pressure and early
detection of preeclampsia, can
help mitigate its severity and
complications.
Obesity Obesity is associated with The rising prevalence of
chronic low-grade obesity underscores the
inflammation, insulin increased risk of preeclampsia
resistance, and endothelial in obese pregnant individuals.
dysfunction, all of which are Managing weight and
factors implicated in the addressing metabolic health
pathogenesis of preeclampsia. before and during pregnancy
are essential strategies for
19
reducing the incidence and
severity of preeclampsia in this
population.
20
SYMPTOMATOLOGY
21
neurovascular changes eclampsia, or neurological
contribute to headaches complications such as
in pre-eclampsia. posterior reversible
encephalopathy syndrome
(PRES). Prompt
evaluation and
management are crucial to
prevent serious
neurological sequelae.
Decreased Urine Reduced renal perfusion Monitoring urine output is
Output due to vasoconstriction essential to assess renal
and decreased function and fluid status.
glomerular filtration rate Oliguria or anuria may
contribute to decreased indicate severe pre-
urine output. eclampsia, renal failure, or
impending eclampsia,
requiring prompt
intervention.
Epigastric or Hepatic involvement, Epigastric pain may
Upper Abdominal hepatic capsular indicate HELLP syndrome
Pain distension, or or liver dysfunction,
subcapsular hematoma necessitating assessment
can cause epigastric of liver enzymes, platelet
pain. count, and consideration
of delivery to prevent
hepatic rupture or
infarction.
Edema Increased capillary While edema is common
permeability and fluid in pregnancy, excessive or
retention due to vascular sudden-onset edema in
changes and renal combination with other
22
dysfunction lead to symptoms may indicate
edema. severe pre-eclampsia or
complications such as
pulmonary edema.
Monitoring for signs of
volume overload and
respiratory distress is
crucial.
Thrombocytopenia Preeclampsia can lead Thrombocytopenia is a
to decreased platelet significant marker of
levels, a condition severe preeclampsia and
known as indicates a higher risk of
thrombocytopenia. This bleeding complications,
occurs due to the such as hemorrhage
activation of platelets during childbirth.
and their consumption in Monitoring platelet levels
response to vascular is crucial in managing
damage and clot preeclampsia and guiding
formation. decisions regarding
delivery timing and mode.
Nausea and Nausea and vomiting Persistent or severe
vomiting are common symptoms nausea and vomiting in
in pregnancy, but when preeclampsia can lead to
they occur or worsen in dehydration, electrolyte
the context of imbalances, and nutritional
preeclampsia, they can deficiencies, impacting
indicate more severe both maternal and fetal
disease. The exact health. Close monitoring
cause of these and management of these
symptoms in symptoms are essential to
preeclampsia is not fully prevent complications.
23
understood but may
relate to altered liver
function and increased
sensitivity to metabolic
changes.
Tachycardia Tachycardia is a Tachycardia in the context
common response to of severe preeclampsia
stress, pain, or can indicate
physiological changes. cardiovascular stress and
In severe preeclampsia, compromised cardiac
tachycardia can result function. It may also be a
from increased sign of impending
sympathetic activity, eclampsia. Monitoring
reduced blood volume heart rate and addressing
due to fluid shifts, or underlying causes are
cardiac strain from crucial in managing severe
hypertension and preeclampsia and
vascular changes. preventing further
complications.
24
X. Pathophysiology
PRE-CLAMPSIA
Decreased fetal
Placental Reduced blood flow to the growth and fetal
Circulation placenta movement
Diagnostic Test
TVS, CBC with PLT Count, UA
PRE-ECLAMPSIA
26
Blood Pressure: 160/100 mmHg or 40
mmHg higher in systolic and 20 mmHg
SEVERE higher in diastolic
PRE-ECLAMPSIA Proteinuria: 5g/2hours
Other symptoms: Severe edema with
rapid weight gain, blurred vision, severe
headache, retinal edema, pulmonary
edema, epigastric pain, nausea and
vomiting
- Eclampsia
Medical Management - HELLP Syndrome
- Magnesium Sulfate (MgSO4) - Organ Damage
Loading dose of 4-6g IVTT and - Abruptio Placenta
maintenance dose of 1-2g/hour IV or IM - FDIU
as ordered - Maternal Stroke
- Hydralazine
50mg PO every 4-6 hours
Good Prognosis
27
XI. Doctor’s Order
28
6AM - Mgso4 loading dose 4gms slow IVTT Now
- 5gms deep IM on each buttocks MD 5gms
Deep IM on each alternate buttocks q4 x 6
doses with toxicity precautions
- Deep Tendon Reflex <+2
- Respiratory Rate <16 Cycle/Min
- U/O <30cc per hour
4/21/24 S/P STAT CS - Post Op
- To PACU x2 hours then ward once stable
- NPO
- VS q15 x2 Hours, q30mins x2 hours, q hourly
x4 hrs then q shift
- IVF: D5LR 1L + Oxytocin 20 IU at 120cc per
hour
- TF: D5LR 1L +OXYTOCIN 20 IU at 120cc per
hour
- Meds:
- Ampicillin 1g IVTT q6
- Hydralazine 5mg IVTT q6 for BP >150 mmHg
systolic
- Ranitidine 50mg IVTT q8 x3 doses
- Tranexamic 500mg IVTT q 8hrs next dose
12nn x2 more doses
- Celecoxib 200mg 1 cap BID
- Flat on bed x6 hours
- O2 @ 2 LPM until awake
- Keep uterus contracted
4/21/24 - Addenum:
10AM - Ketorolac 30mg IVTT q6 x3 doses next dose
at 2pm then shift to Celecoxib PO once on
Soft Diet
29
- Paracetamol 600mg IVTT q6 x3 doses next
dose at 12 pm
- Trammadol 50mg + PNSS 4cc Slow IVTT q6
hours PRN for severe pain
- Refer Accordingly
4/21/24 140/80mmHg - Hydralazine 5mg IVTT x diastolic BP
1:20PM >100mmHg
- May have general liquid diet once with flatus
at 7pm today {4/21/24}
- C/D IVTT meds due
- Start PO meds
- Cefuroxime 500mg 1 cap BID x7 days
- Mefenamic Acid 500mg 1 cap TID for pain
- Mtv+Iron 1 cap once a day
- Amlodipine 10mg 1 tab once a day
- Metorolol 100mg 1 tab BID
- Refer
4/22/24 130/80 mmHg - DAT
8AM - C/D IVF
- Continue Meds
- Start Spironolactone 50mg / tab once a day at
bedtime x7 days
- For wound dressing today
- Apply abdominal binder
- Encourage ambulation
- Remove FC, should void after 6 hours
- I And O q shift
- Increase Oral Fluid Intake
- Daily hygiene and perineal care
- Refer
4/22/24 Hgb 114 - Hold BT
30
3:15PM
4/23/24 BP 120/90 mmHg - May Go Home
8AM TEMP 37.6 - Home Meds:
Hgb 114 - Cefuroxime 500mg 1 tab BID x7 days
WBC 12 - Mtv+Iron 1 tab OD
PLT 261 - Mefenamic Acid 500mg 1 cap TID
- Amlodipine 10mg 1 tab OD
- Follow up check up after 1 week
- advised
31
XII. Diagnostic Tests
32
Fetal Pole:
Crown-Rump Length
(CRL): At around 8
weeks, the CRL of
the fetal pole is
typically between 7
to 13 mm.
Head Diameter:
Measures around 9
to 11 mm.
Abdominal Diameter:
Usually around 4 to
6 mm.
33
make up 42% of the Platelet count:150- 109/L
blood volume. A 400×10⁹/L
normal hematocrit
value for a
nonpregnant woman
is between 36% and
44%.
35
Complete Blood Count
EXAMINATION RESULTS NORMAL VALUES
HEMOGLOBIN 121 g/L 135-175g/L
HEMATOCRIT 35.1% 36.00-42.00
RBC 4.49 10^12/L 4.50-5.00 mmol/I
MCV 78.3 f/L 80.00-100.00fL
MCH 26.9 pg 27.00-31.00 pg/cell
MCHC 343 g/L 320.00-360.00 g/L
LEUCOCYTES NO. 12.24 10^9/L 5.00-10.00x10^9/L
CONC (WBC COUNT)
NEUTROPHILS 81.4% 55.00-65.00
LYMPHOCYTES 12.3% 25.00-40.00
MONOCYTES 4.3% 2.00-6.00
EOSINOPHILS 2.0% 1.00-5.00
BASOPHILS 0.0% 0.00-1.00
PLATELET 261 10^9/L 140-440
Urinalysis
36
XIII. Drug Study
37
including to in pts with occur.
CSF. preexisting
Primarily renal After Administration:
excreted disease. Pts Assess oral cavity
unchanged with history for white patches
in urine. of penicillin on mucus
Moderately allergy is at membranes,
removed by increased tongue.
hemodialysis risk for Monitor daily
. developing pattern of bowel
a severe activity and stool
hypersensiti consistency.
vity reaction Monitor intake
(severe and output and
pruritus, renal function test
angioedem for nephrotoxicity.
a, Be alert for
bronchospa superinfection.
sm
anaphylaxis
).
38
Name of Classification Mechanis Indication Contraindicatio Adverse Effect Nursing
Drug m of n Responsibilities
Action
Generic Therapeutic Hydralazin Treatment of
Coronary Hypotension Before
Name: Classification: e is used to hypertension
artery Tachycardia Administration:
Antihypertensiv treat high , including
disease Headache
Hydralazin e blood hypertension Assess
Mitral Flushing
e pressure. It associated patient’s vital
valvular Nausea/
works by with signs and any
rheumatic vomiting
Brand relaxing the preeclampsi signs/symptom
heart Palpitation
Name: blood a and s of
disease.
vessels so eclampsia Peripheral preeclampsia.
that blood during edema Check doctor’s
Apresoline
can flow pregnancy. order.
Dosage: more easily Review the
5mg through the patient’s
body. medical history
Route:
for any
IVTT
contraindicatio
Frequency n or previous
: every 4-6 adverse
hours reaction to
39
hydralazine.
Ensure proper
dosage
calculation.
During
Administration:
Monitor patient
vital signs.
Watch for
signs of
adverse
reactions.
After
Administration:
Continue
monitoring
patient’s vital
signs
especially the
40
blood pressure
and heart rate.
Assess the
patient for any
signs of
improvement
or worsening
of symptoms.
41
Name of Classification Mechanism of Indication Contraindicatio Adverse Effect Nursing
Drug Action n Responsibilities
Generic >Pre- To prevent Parenteral CNS: drowsiness Before:Take an
Name: eclampsia Magnesium control administration depress reflexes, appropriate
Magnesiu woman: 4g IV Sulfate is seizure in contraindicated placid paralysis. seizure
m Sulfate in 250 ml. essential pre- in patient with hypothermia CV: precaution.
D5W with element for eclampsia heart block hypotension,
Brand normal saline muscle and To manage myocardial lushing During:
Name: and 4-5 g. nerve preterm damage. bradycardia, Check
Magnesiu deep IM into transmission labor Use cautiously in circulatory Magnesiumlevel
m Sulfate buttock Extracellular patients with collapse, repeatd doses.
alternate in fluid levels: impaired renal Disappearance of
depress
every 4 hrs. 1.5-2.5 mg/L. function Use knee. Jerl and
cardiacfunction
P.R.N 4g IV. Mg depresses cautiously in patellar reflexes
Skin:
Lodding dose the CNS is a sign of
pregnant diaphoresis
then 1 2 qhr. andcontrols impeding
woman
as LV infusion convulsion by magnesium
during labor
Dose should blocking toxicity.
notexceed 30- release of Monitor urine
40 g. daily acetycholine at intake and output.
the myoneutral
junction Also, After:
42
mg decrease Observe
sensitivity of neonates for
motor end for signs of
plate to magnesium
acytycholine toxicity.
and decreases
the excitability
of the mother ,
membrane as
a laxative it
acts in the
small and
target intestine
to attract and
retain water in
the intestinal
lumen,
increasing
intraluminal
pressure, also
releases
cholycystokini
43
n.
44
Name of Classification Mechanism Indication Contraindication Adverse Nursing
Drug of Action Effect Responsibilities
Antiemetic, Metoclopram Metoclopra
Generic Hypersensitivi Extrapyrami Before
Prokinetic ide works mide is
Name: ty to dal administration:
agent primarily by indicated for
Metoclopra metocloprami symptoms
antagonizing the Assess the
mide de or any (e.g.,
dopamine treatment of patient's medical
component of dystonia,
Brand receptors in gastroesop history, allergies,
the dyskinesia)
Name: the hageal and current
formulation. Sedation
Reglan chemorecept reflux medications.
Gastrointestin Diarrhea
or trigger disease Check for
Dosage: al obstruction, Tardive
zone (CTZ) (GERD), contraindications
perforation, or dyskinesia
of the brain. diabetic and potential
1 AMP
hemorrhage. (a
It also gastropares drug interactions.
Route: Per Pheochromoc potentially
sensitizes is, nausea Monitor vital
Orem ytoma irreversible
tissues to and signs, especially
the effects of vomiting Seizure movement
Frequency: blood pressure,
acetylcholine associated disorders disorder)
STAT as
, which with Hyperprolac
metoclopramide
enhances chemothera tinemi
can cause
gastric py, and Neuroleptic
hypotension.
motility and postoperativ malignant
syndrome During
45
accelerates e nausea
(rare but administration:
gastric and
serious)
emptying. vomiting. Administer the
medication as
prescribed,
ensuring the
correct dosage
and route.
Monitor the
patient for any
signs of adverse
reactions, such
as extrapyramidal
symptoms or
sedation.
Educate the
patient about the
medication,
including its
purpose, dosage,
potential side
effects, and any
46
necessary
precautions.
After
administration:
Monitor the
patient's
response to the
medication,
assessing for
improvements in
symptoms or the
development of
adverse effects.
Document the
administration
and the patient's
response in the
medical record.
Provide
appropriate
supportive care
47
as needed, such
as managing
adverse effects
or addressing
any concerns the
patient may have.
48
Name of Classification Mechanism Indication Contraindicatio Adverse Nursing
Drug of Action n Effect Responsibilities
Generic Therapeutic Ketorolac, Ketorolac is This drug is Headache, 1. Check doctor’s
Name: Classification like other a Non- contraindicated drowsiness, order to avoid
: NSAIDs, steroidal to dizziness, mistake.
Ketorolac Non-steroidal blocks anti- pregnant patient pallor, 2. Observe the 10
anti- cyclooxygen inflammator who are sweating, RIGHTs in
Brand inflammatory ases (COX), y drug hypersensitive to dry mouth, administering the
Name: drug (NSAID) which are (NSAID) Ketorolac drugs. diarrhea, drug.
enzymes and has And patients with edema, 3. Assess and
Toradol Pregnancy that convert antipyretic, cross – sensitive vasodilation accurately record
category: C arachidonic analgesic with and maternal vital
Actual/ acid into and anti- other NSAIDs injection signs.
Dosage/ prostaglandi inflammator and site pain. 4. Assess the
Route/ ns, y during pre or client’s history of
Frequency
prostacyclin, properties.2 perioperative allergy to the drug
and It is use. to avoid
30mg IVTT
thromboxane indicated for complications.
q6 X 3
. The short term 5. Encourage client
DOSES
inhibition of manageme to report severe
these nt of acute pain for prompt
substances pain that intervention.
49
decreases requires the 6. Tell patient to
pain, fever, calibre of avoid activities
and pain requiring
inflammation manageme alertness because
.[4] nt offered this drug can
Ketorolac by opioids. cause headache,
does so by dizziness and
inhibiting drowsiness.
both 7. Instruct client to
cyclooxygen call the attention
ase-1 and of any health care
cyclooxygen professional when
ase-2. It has difficulty of
higher breathing is
demonstrate experienced to
d potency give prompt
than most intervention.
other 8. Terminate or
NSAIDs discontinue
infusion if uterine
hypersensitivity
occurs.
50
51
XIV. Surgical Procedure
Indication:
Patient Preparation:
Procedure Steps:
52
the uterine wall to access the baby. The baby is delivered through the uterine
incision, ensuring proper handling to prevent neonatal injury.
5. Cord Clamping and Placental Delivery: After the baby is delivered, the umbilical
cord is clamped and cut. The placenta is then carefully removed from the uterine
cavity to minimize the risk of retained placenta and postpartum hemorrhage.
6. Uterine Repair and Closure: The uterine incision is closed in layers using
absorbable sutures to achieve hemostasis and prevent uterine rupture. The
peritoneum and rectus muscles are approximated, and the skin incision is closed
with sutures or staples.
7. Postoperative Care: Mrs. A is transferred to the recovery area for close monitoring
of vital signs, bleeding, and pain control. Ongoing assessment of uterine tone and
lochia is performed to detect any signs of complications such as uterine atony or
retained placenta. Maternal-fetal bonding and breastfeeding support are provided as
appropriate.
Outcome:
Emergency cesarean section for severe pre-eclampsia aims to safely deliver the
baby while minimizing maternal and fetal risks associated with prolonged labor and
vaginal delivery in the presence of hypertensive emergencies. This surgical intervention
helps prevent life-threatening conditions and ensures optimal outcomes for both mother
and baby.
53
XV. Nursing Theories
Jean Watson's theory emphasizes the caring relationship between the nurse and
the patient, focusing on the humanistic aspects of nursing. In severe pre-eclampsia, this
theory underscores the importance of a compassionate and empathetic approach.
Nurses can build a therapeutic relationship with the patient, offering emotional support,
active listening, and reassurance. This caring approach can help alleviate anxiety and
stress, which are common in patients with severe pre-eclampsia.
Sister Callista Roy's model focuses on how individuals adapt to changes in their
environment. It emphasizes the role of nursing in promoting successful adaptation to
health challenges. Severe pre-eclampsia can significantly disrupt a woman's normal
physiological and psychological balance. Nurses using Roy's model would assess how
the patient is adapting to the stress of the condition, including physiological responses
(e.g., blood pressure, edema), self-concept, and social roles (e.g., family relationships).
Nursing interventions aim to support adaptation, providing care and education to help
the patient and her family to adjust to the condition and treatment.
54
Self-Care Deficit Theory
This theory, developed by Dorothea Orem, is based on the idea that individuals
can care for themselves, but may require nursing intervention when they cannot meet
their own care needs. Patients with severe pre-eclampsia often require substantial
assistance due to their condition's risks and limitations on activity. Nurses can assess
self-care deficits in areas such as medication management, monitoring symptoms, and
mobility, providing necessary support and education. The goal is to help the patient
regain as much independence as possible while ensuring safety and stability.
55
XVI. Nursing Care Plan
- Blood
56
Pressure:
160/100
mmHg
- Pulse
Rate :89 bpm
- Respiratory
Rate: 21 cpm
- Temperaure:
36.5OC
- SpO2: 98%
57
Date/ Cues Nursing Patient Nursing Rationale Evaluation
Time Diagnosis Outcome Interventions
Subjective: Risk for fall After 8 Assessment Regular After 8
April
“Ga blur akong related to hours of and assessment and hours of
22,
panan-aw kauban sa visual nursing monitoring monitoring of vital nursing
2024
gasakit nako na ulo” disturbance intervention, vital signs signs, including intervention,
5:00 as verbalized by the related AEB the patient and also the blood pressure, the patient
58
- Oxygen in place, can help manage
Saturation: 98% including visual
padded side disturbances and
rails and prevent
suction complications
equipment at : Excessive
the bedside. stimulation can
Provide increase anxiety
education on and blood
signs and pressure,
symptoms of exacerbating
worsening visual
preeclampsia disturbances and
and the other
importance of preeclampsia
reporting any symptoms.
changes Visual
promptly. disturbances can
be a precursor to
eclampsia, which
is characterized
by seizures.
59
Precautions help
ensure the safety
of the patient
during a seizure
episode.
Empowering the
patient with
knowledge helps
in early detection
of complications,
including visual
disturbances, and
promotes timely
intervention.
60
Date/ Cues Nursing Patient Nursing Rationale Evaluation
Time Diagnosis Outcome Interventions
Subjective: Acute pain After 8 hrs Provided Regular After 8hrs of
April
related to of nursing regular assessment nursing
22, “Sakit kayo and
surgical intervention assessment ensures intervention
2024 tinahian” verbalized
incision. patient will and timely patient
by the patient.
5:00 pm verbalize management intervention to verbalized
reduce of of pain. alleviate reduce of pain
61
infection or
improper
healing.
Regular
assessment
of the uterine
fundus aids in
detecting
abnormal
bleeding.
Helps prevent
complications
such as deep
vein
thrombosis
(DVT) and
aids in the
recovery
process.
Deep
breathing
exercises
62
promote lung
expansion
and prevent
respiratory
complications.
To manage
postoperative
discomfort.
63
Date/ Cues Nursing Patient Nursing Rationale Evaluation
Time Diagnosis Outcome Interventions
April 22, Subjective: Impaired skin After 8hours - Evaluate - For Goal was met
2024 "Gapang hupong integrity related of nursing mentation. confusion after 8hours of
5:00 pm akong mga tiil" as to as interventions - Restrict or nursing
verbalized by the evidenced by patient will be sodium and personality interventions
patient. edema. able to fluid intake. changes. patient was
verbalize - Advised to - To able verbalized
Objective: understanding elevate the emphasize understanding
(+) Edema of individual edematous dietary/fluid of individual
dietary/fluid extremities, restriction dietary/fluid
Vital Signs: restrictions. change - To reduce restriction.
- Temperature: position tissue .
36.5⁰C frequently. pressure
- Pulse Rate: - Stress the and risk for
89bpm need for skin
- Respiratory mobility and breakdown.
Rate: 21cpm frequent - To prevent
- Blood Pressure: position stasis and
160/100 mmHg changes. risk of
- Oxygen - Identify signs tissue
Saturation: 96% requiring injury.
64
notification of - To ensure
healthcare timely
provider. evaluation/
intervention
65
Date/ Cues Nursing Patient Nursing Rationale Evaluation
Time Diagnosis Outcome Interventions
April Subjective: Risk for After a series Monitor To measure Patient
22, “Medyo gapula infection of nursing patient’s vital body basic demonstrated
2024 akonng tahi ug related to interventions signs, functions, understanding
5:00 medyo hapdi siya postoperative the patient will including elevated body about the risk
pm ilihok” of cesarean demonstrate temperature temperature factors and
section. understanding and blood are one the signs of
Objective: about the risk pressure. sign of infection.
- Discomfort to factors and Position the infection, it is Patient
site of incision what to look patient in also important remained
- Weakness for signs of comfortable to monitor afebrile as
- Facial grimace infection. position that blood evidenced by
noted. After 8 hours could relieve pressure temperature
of nursing discomfort, since client of 36.5 C, and
Vital Signs: interventions Educate the has pre- the patient
- Blood the patient will patient about eclampsia. remained free
Pressure: remain the possible To relieve from infection.
90/70 mmHg afebrile and signs of feeling of
- Pulse Rate: free from infection. discomfort, so Goal met.
78bpm infection Teach the that client
66
- Respiratory patient about would comply
Rate: 22 cpm proper to the
- Temperature: perineal interventions.
37OC care, To improve
- SpO2: 98% especially proper
before and healing
after renal or without the
bowel invasion of
activity. infection.
Encourage Adequate
the patient to hydration can
increase oral help improve
fluid intake. immune
Encourage system
the patient to function to
increase promote
intake of proper
Protein and healing.
Vitamin C – Protein is
rich food. essential for
Emphasize repairing and
the necessity building
67
of taking tissues during
antibiotics as wound
prescribed healing and
by the Vitamin C has
physician, antioxidant
especially properties,
the dosage, protecting
time and cells from
length of damage and
therapy. supporting the
Emphasize immune
to the patient system.
to report any To ensure
signs of successful
infection and treatment and
problems reduce the
encountered. risk of
antibiotic
resistance,
follow your
physician’s
instructions
68
for dosage,
timing, and
length of
therapy
precisely.
- To ensure
immediate
response for
possible
complications.
69
XVII. Discharge Plan
70
Referral normal activities.
Diet Balanced Nutrition: Emphasize a well- To support her physical
balanced diet that includes a variety of recovery and nutrients can
fruits, vegetables, whole grains, lean help optimize healing and
proteins, and healthy fats. support overall health as the
Hydration: Encourage adequate hydration body goes through this
by drinking plenty of water throughout the challenging period.
day. Staying hydrated can
support normal bodily
functions and help the body
cope with physical and
emotional demands of the
situation.
Spiritual Encourage the client to continue to seek Positive beliefs, comfort, and
God’s guidance and enlightenment. strength gained from religion,
meditation, and prayer can
contribute to well-being.
(Rich, 2020)
Share spiritual thoughts that can Scripture has an amazing
encourage the patient. way of uplifting spirit and
encouraging people.
(Nouran, 2018)
71
XVIII. Prognosis
This chapter deals with the notion about the phasing of a patient’s recovery as
anticipated by the usual process and idiosyncrasy of the disease state. Accordingly,
prognosis relatively amends patient charted implications (Selim et. al., 2020)
72
patient was able to comply with the
necessary medications and treatment
that the patient needs to undergo
Final Prognosis
73
XIX. Recommendation
To the Patient:
For the patient diagnosed with severe pre-eclampsia, nursing recommendations focus
on close monitoring of blood pressure, urine output, and fetal well-being. Patients
should be educated about signs and symptoms of worsening pre-eclampsia, such as
severe headaches, visual disturbances, and abdominal pain, and instructed to seek
immediate medical attention if these occur. Additionally, strict bed rest and medication
compliance, often including antihypertensive drugs like labetalol or hydralazine, are
crucial in managing pre-eclampsia to prevent further complications like eclampsia or
HELLP syndrome.
To the Family/Watcher:
Family or watchers of the patient with severe pre-eclampsia should be informed about
the condition's seriousness and potential risks to both the mother and the baby. They
should be encouraged to provide emotional support and assist with daily activities as
needed, promoting a calm and stress-free environment for the patient.
Student nurses involved in the care of a patient with severe pre-eclampsia should focus
on enhancing their knowledge about the condition, its pathophysiology, and evidence-
based nursing interventions. They should actively participate in monitoring vital signs,
administering medications under supervision, and assisting with patient education to
improve outcomes and develop their clinical skills.
Health care providers managing patients with severe pre-eclampsia should ensure
timely and comprehensive assessment, including regular blood pressure monitoring,
74
urine analysis for proteinuria, and fetal monitoring through non-stress tests or
biophysical profiles. Collaboration with obstetricians, neonatologists, and other
specialists is essential to provide optimal care, considering potential complications like
preterm birth, placental abruption, or fetal distress.
To the community:
75
X. Reference
76